Skip Navigation


Rheumatology Advance Access originally published online on February 12, 2009
Rheumatology 2009 48(4):416-420; doi:10.1093/rheumatology/kep004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/4/416    most recent
kep004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nyhäll-Wåhlin, B.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyhäll-Wåhlin, B.-M.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis

Britt-Marie Nyhäll-Wåhlin1, Ingemar F. Petersson2, Jan-Åke Nilsson3, Lennart T. H. Jacobsson3, Carl Turesson3 and the BARFOT study group*

1Department of Rheumatology, Falun Hospital, Falun, 2Department of Rheumatology, Lund University Hospital, Lund and 3Department of Rheumatology, Malmö University Hospital, Malmö, Sweden.

Correspondence to: Britt-Marie Nyhäll-Wåhlin, Department of Rheumatology, Falun Hospital, SE-791 82 Falun, Sweden. E-mail: britt-marie.nyhall-wahlin{at}ltdalarna.se


   Abstract

Objectives. To identify patients with severe extra-articular RA (ExRA) in an early RA cohort and to investigate potential risk factors.

Methods. From a cohort (n = 2900) in a structured programme for newly diagnosed RA, 40 patients with severe ExRA after RA diagnosis were identified. Disease activity score (DAS28), functional disability (HAQ) and treatment with glucocorticosteroids (GCs) and DMARDs were assessed regularly. Cases with ExRA were compared with RA controls from the same cohort matched for age, sex and duration of symptoms at inclusion.

Results. Patients who developed severe ExRA were more often current smokers and had higher mean DAS28, HAQ and CRP at baseline. Among the ExRA cases, 93% had a positive RF vs 59% of the controls. The area under the curve (AUC) of DAS28 odds ratio (OR) 7.79/S.D.; 95% CI 3.04, 19.95, HAQ (OR 2.30/S.D.; 95% CI 1.37, 3.88) and CRP (OR 3.05/S.D.; 95% CI 1.77, 5.26) during the first 2 years of follow-up were strong predictors of subsequent development of ExRA. The most frequently used DMARDs were MTX and SSZ, with similar frequency and duration of treatment among cases and controls. The cases were treated with GC before onset of ExRA more frequently (73 vs 47%; P = 0.005) and with higher mean cumulative dose (3667 vs 2037 mg, P = 0.015).

Conclusions. High levels of disease activity and disability during the first 2 years after RA diagnosis, smoking and RF predict the development of severe extra-articular RA.

KEY WORDS: Extra-articular manifestations, Early RA, Disease activity burden, Smoking


*The BARFOT study group includes: Monica Ahlmén, Johan Bratt, Kristina Forslind, Ingiä ld Hafström, Catharina Keller, Ido Leden, Bengt Lindell, Björn Svensson, Annika Teleman and Jan Theander.

Submitted 14 September 2008; revised version accepted 7 January 2009.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.